Intrinsic Value

Cara Therapeutics, Inc. (CARA)

$0.91

+0.04 (+4.72%)

Enterprise Value -99,651.78
Net Debt -9.02
Equity Value -99,642.76
Shares Outstanding 54.15
Equity Value Per Share -1,840.16



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt